Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance

被引:22
|
作者
Zink, Richard C. [1 ]
Huang Qin [2 ]
Zhang Lu-Yong [3 ]
Bao Wen-Jun [1 ]
机构
[1] SAS Inst Inc, Cary, NC USA
[2] SFDA, Ctr Drug Evaluat, Beijing 100053, Peoples R China
[3] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Peoples R China
关键词
Disproportionality; Statistics; Graphics; Pharmacovigilance; Spontaneously-reported adverse events; SIGNAL GENERATION;
D O I
10.1016/S1875-5364(13)60035-7
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
AIM: Combine disproportionality analysis with dynamically interactive graphics to understand spontaneously-reported adverse events in pharmacovigilance. METHODS: Four statistical methods, including Reporting Odds Ratio, Proportional Reporting Ratio, Multi-Item Gamma Poisson Shrinker and Bayesian Confidence Propagation Neural Network that are used for computing disproportionality are described. Tree maps and other graphical techniques are used to display the disproportionality results. RESULTS: Spontaneously-reported adverse events in pharmacovigilance are collected from physicians, patients, or the medical literature by regulatory agencies, pharmaceutical companies and device manufacturers to monitor the safety of a product once it reaches the market. In order to identify potential safety-signals, disproportionality analysis methods compare the rate at which a particular event of interest co-occurs with a given drug with the rate this event occurs without the drug in the event database. Tree maps are employed to interactively display the adverse events for particular drugs and compare the adverse events among the drugs. CONCLUSIONS: Interactive graphical displays of disproportionality allow the analyst to quickly identify safety signals and perform additional follow-up analyses. Combining statistical methods with dynamically interactive graphics affords insights into the data inaccessible by traditional analysis methods.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 50 条
  • [1] DISPROPORTIONALITY ANALYSIS FOR PHARMACOVIGILANCE OF MEDICAL DEVICE RELATED ADVERSE EVENTS REPORTED TO THE FDA
    Duggirala, H. J.
    Herz, N. D.
    Canos, D. A.
    Sullivan, R.
    Schaaf, Richard
    Pinnow, E.
    Marinac-Dabic, D.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S131 - S131
  • [2] The Reporting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in PharmacoVigilance (READUS-PV)
    Fusaroli, M.
    Raschi, E.
    Salvo, F.
    Khouri, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 43 - 43
  • [3] Antibiotics-Induced Liver Injury: A Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events
    Mendes, D.
    Dias, P.
    Alves, C.
    Batel-Marques, F.
    DRUG SAFETY, 2015, 38 (10) : 1006 - 1006
  • [4] Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events
    Mendes, D.
    Alves, C.
    Batel-Marques, F.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (03) : 307 - 313
  • [5] Analysis of Spontaneously Reported Adverse Events
    Nakamura, Mitsuhiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 549 - 556
  • [6] Serious adverse events with infliximab: Analysis of spontaneously reported adverse events
    Hansen, Richard A.
    Gartlehner, Gerald
    Powell, Gregory E.
    Sandler, Robert S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (06) : 729 - 735
  • [7] Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization's pharmacovigilance database
    Modingam, Pamella
    Faillie, Jean-Luc
    Campillo, Jeremy T.
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (11):
  • [8] Analysis of Hydroxychloroquine Adverse Events Reported in the WHO Pharmacovigilance Database
    Ahmed, Nehad J.
    Alshehri, Ahmed M.
    Almalki, Ziyad S.
    Alahmari, Abdullah K.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (01): : 25 - 30
  • [9] CLOZAPINE ASSOCIATED CARDIAC ADVERSE EVENTS: A REAL-WORLD PHARMACOVIGILANCE AND DISPROPORTIONALITY ANALYSIS
    Thotamgari, Sahith Reddy
    Dhaliwal, Lovekirat
    Bath, Anandbir
    Brar, Vijaywant
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 334 - 334
  • [10] Comparison of pharmacovigilance algorithms in reported voriconazole adverse events
    Eiden, Celine
    Grand, Anais
    Peyriere, Helene
    Hillaire-Buys, Dominique
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 67 - 67